A Pharmaceuticals and Healthcare (Contract Research & Manufacturing Services (CRAMS)) entity from India is looking to sellout.
BUSINESS BRIEF
The Company has WHO GMP Approved and US FDA authorized manufacturing unit producing Injectables, Tablets, Eyes/Ear drops. The operations of the firm closed in 2017 due to Working Capital crunch, more than 60 equipments are in reusable condition. The Company has 20 acre land, All QA-QC Equipments are in place, RO Water / HEPA filter functional, and more than 60 product licenses are available. Upgradation for additional production is also possible The turnaround time would be 100 working days. along with the availability of all documents for due diligence.
Proposal
 Deal Size
|
INR 450 to 550 Mn |
| Justification: | |
| Motives For Sellout | Raising Capital |
Industry Pharmaceuticals and Healthcare |
Sub-Industry Contract Research & Manufacturing Services (CRAMS) |
| Entity is open for Investor Keen on Special Situations/distress assets funding | |
Business Operating Information
Industry
Pharmaceuticals and Healthcare
Sub-Industry
Contract Research & Manufacturing Services (CRAMS)
Division
Division`s Market Share
Not Disclosed
Division`s Growth rate in 3 years
Not Disclosed
Division`s Key Partnership`s
Not Disclosed
Division`s Buyers/Customers
Division`s Plant Location
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Division`s Products/Services
Market Share %
Not Disclosed
Growth rate in 3 years
Not Disclosed
Key Partnerships
Not Disclosed
Business Strength
Access strength
Justification N/A
Manufacturing strength
Justification N/A
Financial Information
| 2017 (in INR) | 2018 (in INR) | 2019 (in INR) | 2020 (in INR) | ||
|---|---|---|---|---|---|
| Sales | N.D | N.D | N.D | N.D | |
| EBDITA | N.D | N.D | N.D | N.D | |
| PAT | N.D | N.D | N.D | N.D | |
| TANGIBLE NET WORTH | N.D | N.D | N.D | N.D | |
| LONG TERM DEBT | N.D | N.D | N.D | N.D | |
| TOTAL DEBT | N.D | N.D | N.D | N.D | |
CONTACT BUSINESS
If you are interested in connecting with business please send an Expression of Interest.
EXPRESS INTEREST MARK FAVOURITESHARE VIA
CONTACT DETAILS
